Skip to main content

romosozumab

Generic: romosozumab·Brand: Evenity

romosozumab: 2 clinical trials tracked.

romosozumab evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about romosozumab, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Clinical Trials (2)

Investigating the Efficacy of Romosozumab in Augmenting Bone Density and Muscle Mass to Enhance the Outcomes of Spine Surgery

NCT06973109·Phase 2
Withdrawn

Primary endpoint: Change in Hounsfield Units (HU) at L1 Vertebra

InterventionalRandomizeddouble0 targetStarted 2026-06Completion 2027-061 site · United StatesUniversity of Pittsburgh

A Phase 3, Open-Label, Multicenter, Randomized Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta

NCT05972551·Phase 3·AMGN
Active, not recruiting

Primary endpoint: Number of Clinical Fractures

InterventionalRandomizedopen111 targetStarted 2024-04Completion 2027-0750 sites · Australia, Austria, Belgium, Canada…Amgen